+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global DNA Vaccines Market 2019-2027

  • ID: 4827813
  • Report
  • Region: Global
  • 172 pages
  • Triton Market Research
1 of 3

FEATURED COMPANIES

  • Astellas Pharma, Inc.
  • Eli Lilly And Company
  • Eurogentec S.A.
  • Glaxosmithkline, Inc.
  • Merck & Co.
  • Novartis AG
  • MORE

Market Outlook

The author predicts that the global market for DNA vaccines would witness a CAGR of 42.03% over the forecast period 2019-2027.DNA vaccines are the third generation of vaccines that contain DNA responsible for the coding of specific proteins (antigens) from pathogens. Genetically-engineered DNA is injected into the cells (humans/animals), so that these cells can produce antigens through protective immunological response. Contrary to conventional vaccines, DNA vaccines use DNA from infectious organisms only, have no potential risk of infections and provide humoral, as well as cell-mediated immunity. DNA vaccines possess the ability to induce a wide range of immune responses and hence, are extensively researched for potential benefits to cure diseases such as HIV/AIDS, cancer and others. The increase in cases of chronic and infectious diseases, swelling usage of DNA vaccines for animal healthcare and a surge in the development of new vaccines are driving the global DNA vaccines market. On the other hand, issues like the lack of legal & ethical framework and strict regulations by the government restrict the growth of the market. Opportunities like steady vaccines that are easier to store & transport, rising number of clinical trials on humans and growth in the demand for gene therapy supplement the growth of the market. However, factors such as variation in the regulatory pathway and the points of consideration regarding environmental valuation are proving to be a massive challenge for the DNA vaccines market growth.

Regional Outlook
The regions of Europe, Asia-Pacific, Latin America, the Middle East and Africa and North America form the global DNA vaccines market. North America is the global leader in the DNA vaccines market. The North America DNA vaccines market is primarily driven by high investments to support the development of human DNA vaccines in the countries of the US and Canada. Furthermore, a large number of pets that are one of the primary consumers of DNA vaccines, also positively influence the growth of the DNA vaccines market, since a significant percentage of the population in this region owns pets. According to the National Center for Biotechnology Information, the Canadian government made an investment of $440 million in 2015 for the advancement & development of DNA vaccines in the country, focusing on both the humans and animals.

Competitive Outlook
Some of the companies present in the market are Zoetis, Inc., Xenetic Biosciences, Inc., Vical, Incorporated, VGXI, Sanofi, Novartis AG, Merial Limited (acquired by Boehringer Ingelheim), Merck & Co., Madison Vaccines, Incorporated (MVI), Inovio Pharmaceuticals, Inc., GlaxoSmithKline, Inc., Eurogentec S.A., Eli Lilly and Company, Eli Lilly and Company, Dendreon Corporation (acquired by Sanpower Group) and Astellas Pharma, Inc.
Novartis AG is a Switzerland-based healthcare company headquartered in Basel. It manufactures, develops and provides innovative healthcare solutions worldwide. The company mainly focuses on innovative patented medicines, biosimilar pharmaceuticals, eye care devices and generics. These segments also franchise neuroscience, ophthalmology, dermatology, immunology; respiratory, cardio-metabolic and other medicines; and cell and gene therapies. In 2015, the company’s products reached an anticipated 520 million patients, and the company aspires to reach a target of 1 billion in the coming years. In 2016, Novartis achieved net sales of around $48.5 billion. The company has its presence globally, in more than155 countries.

Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Astellas Pharma, Inc.
  • Eli Lilly And Company
  • Eurogentec S.A.
  • Glaxosmithkline, Inc.
  • Merck & Co.
  • Novartis AG
  • MORE
1. Global DNA Vaccines Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Outlook
2.2.1. Threat of New Entrants
2.2.2. Threats of Substitute Product
2.2.3. Bargaining Power of Buyer
2.2.4. Bargaining Power of Supplier
2.2.5. Intensity of Competitive Rivalry
2.3. Vendor Scorecard
2.4. Value Chain Outlook
2.5. Key Insights
2.6. Regulatory Framework
2.7. Key Buying Outlook
2.8. Market Drivers
2.8.1. Surge in New Vaccine Development
2.8.2. Rising Usage of DNA Vaccines for Animal Healthcare
2.8.3. Rising Prevalence of Chronic and Infectious Diseases
2.9. Market Restraints
2.9.1. Lack of Legal and Ethical Framework
2.9.2. Stringent Government Regulations
2.10. Market Opportunities
2.10.1. Growing Demand for Gene Therapy
2.10.2. Steady Vaccines Are Easy to Store and Transport
2.10.3. Increasing Number of Clinical Trials on Humans
2.11. Market Challenges
2.11.1. Variation in the Regulatory Pathway and the Points of Consideration Regarding Environmental Valuation

3. DNA Vaccines Market Outlook - by Type
3.1. Animal DNA Vaccine
3.2. Human DNA Vaccine

4. DNA Vaccines Market Outlook - by Application
4.1. Human Disease
4.2. Veterinary Disease

5. DNA Vaccines Market Outlook - by Technology
5.1. Plasmid DNA Vaccines
5.2. Plasmid DNA Delivery

6. DNA Vaccines Market Outlook - by Region
6.1. North America
6.1.1. Market by Type
6.1.2. Market by Technology
6.1.3. Market by Application
6.1.4. Country Analysis
6.1.4.1. The United States
6.1.4.2. Canada
6.2. Europe
6.2.1. Market by Type
6.2.2. Market by Technology
6.2.3. Market by Application
6.2.4. Country Analysis
6.2.4.1. The United Kingdom
6.2.4.2. France
6.2.4.3. Germany
6.2.4.4. Spain
6.2.4.5. Italy
6.2.4.6. Russia
6.2.4.7. Rest of Europe
6.3. Asia-Pacific
6.3.1. Market by Type
6.3.2. Market by Technology
6.3.3. Market by Application
6.3.4. Country Analysis
6.3.4.1. India
6.3.4.2. China
6.3.4.3. Japan
6.3.4.4. Australia & New Zealand
6.3.4.5. South Korea
6.3.4.6. Asean Countries
6.3.4.7. Rest of Asia-Pacific
6.4. Latin America
6.4.1. Market by Type
6.4.2. Market by Technology
6.4.3. Market by Application
6.4.4. Country Analysis
6.4.4.1. Brazil
6.4.4.2. Mexico
6.4.4.3. Rest of Latin America
6.5. Middle East and Africa
6.5.1. Market by Type
6.5.2. Market by Technology
6.5.3. Market by Application
6.5.4. Country Analysis
6.5.4.1. Saudi Arabia
6.5.4.2. Turkey
6.5.4.3. The United Arab Emirates
6.5.4.4. South Africa
6.5.4.5. Rest of Middle East & Africa

7. Competitive Landscape
7.1. Astellas Pharma, Inc.
7.2. Dendreon Corporation (Acquired by Sanpower Group)
7.3. Eli Lilly and Company
7.4. Eurogentec S.A.
7.5. Glaxosmithkline, Inc.
7.6. Inovio Pharmaceuticals, Inc.
7.7. Madison Vaccines Incorporated (Mvi)
7.8. Merck & Co.
7.9. Merial Limited (Acquired by Boehringer Ingelheim)
7.10. Novartis AG
7.11. Sanofi
7.12. Vgxi
7.13. Vical, Incorporated
7.14. Xenetic Biosciences, Inc.
7.15. Zoetis, Inc.

8. Methodology & Scope
8.1. Research Scope
8.2. Sources of Data
8.3. Research Methodology

List of Tables
Table 1 Global DNA Vaccines Market by Region 2019-2027 ($ Million)
Table 2 Interventions and Phase of Some Diseases/Conditions
Table 3 Regulations to Follow Before Commercialization
Table 4 Temperature Requirements in Preservation for Various Vaccines
Table 5 Approaches Being Tested to Enhance the Low Immunogenicity
Table 6 Clinical Trials on Humans Involving DNA Vaccines
Table 7 Global DNA Vaccines Market by Type 2019-2027 ($ Million)
Table 8 Global DNA Vaccines Market by Technology 2019-2027 ($ Million)
Table 9 Global DNA Vaccines Market by Application 2019-2027 ($ Million)
Table 10 Global DNA Vaccines Market by Region 2019-2027 ($ Million)
Table 11 North America DNA Vaccines Market by Type 2019-2027 ($ Million)
Table 12 North America DNA Vaccines Market by Technology 2019-2027 ($ Million)
Table 13 North America DNA Vaccines Market by Application 2019-2027 ($ Million)
Table 14 North America DNA Vaccines Market by Country 2019-2027 ($ Million)
Table 15 Europe DNA Vaccines Market by Type 2019-2027 ($ Million)
Table 16 Europe DNA Vaccines Market by Technology 2019-2027 ($ Million)
Table 17 Europe DNA Vaccines Market by Application 2019-2027 ($ Million)
Table 18 Europe DNA Vaccines Market by Country 2019-2027 ($ Million)
Table 19 Asia-Pacific DNA Vaccines Market by Type 2019-2027 ($ Million)
Table 20 Asia-Pacific DNA Vaccines Market by Technology 2019-2027 ($ Million)
Table 21 Asia-Pacific DNA Vaccines Market by Application 2019-2027 ($ Million)
Table 22 Asia-Pacific DNA Vaccines Market by Country 2019-2027 ($ Million)
Table 23 Latin America DNA Vaccines Market by Type 2019-2027 ($ Million)
Table 24 Latin America DNA Vaccines Market by Technology 2019-2027 ($ Million)
Table 25 Latin America DNA Vaccines Market by Application 2019-2027 ($ Million)
Table 26 Latin America DNA Vaccines Market by Country 2019-2027 ($ Million)
Table 27 Middle East and Africa DNA Vaccines Market by Type 2019-2027 ($ Million)
Table 28 Middle East and Africa DNA Vaccines Market by Technology 2019-2027 ($ Million)
Table 29 Middle East and Africa DNA Vaccines Market by Application 2019-2027 ($ Million)
Table 30 Middle East and Africa DNA Vaccines Market by Country 2019-2027 ($ Million)

List of Figures
Figure 1 Global DNA Vaccines Market 2019-2027 ($ Million)
Figure 2 Value Chain Analyses for DNA Vaccine Industry
Figure 3 North America DNA Vaccines Market 2019-2027 ($ Million)
Figure 4 Global DNA Vaccines Market in Veterinary Diseases 2019-2027 ($ Million)
Figure 5 Share of Trials by Vaccine Target in 2016
Figure 6 Segment of Clinical Trials of DNA Vaccines by Cancer Marks in 2016 (%)
Figure 7 Clinical Trials of Gene Therapy
Figure 8 Global DNA Vaccines Market in Animal DNA Vaccines 2019-2027 ($ Million)
Figure 9 Global DNA Vaccines Market in Human DNA Vaccines 2019-2027 ($ Million)
Figure 10 Global DNA Vaccines Market Share by Application 2018 & 2027 (%)
Figure 11 Global DNA Vaccines Market in Human Diseases 2019-2027 ($ Million)
Figure 12 Global DNA Vaccines Market in Veterinary Diseases 2019-2027 ($ Million)
Figure 13 Global DNA Vaccines Market in Plasmid DNA Vaccines Technology 2019-2027 ($ Million)
Figure 14 Global DNA Vaccines Market in Plasmid DNA Delivery Technology 2019-2027 ($ Million)
Figure 15 The United States DNA Vaccines Market 2019-2027 ($ Million)
Figure 16 Canada DNA Vaccines Market 2019-2027 ($ Million)
Figure 17 The United Kingdom DNA Vaccines Market 2019-2027 ($ Million)
Figure 18 France DNA Vaccines Market 2019-2027 ($ Million)
Figure 19 Germany DNA Vaccines Market 2019-2027 ($ Million)
Figure 20 Spain DNA Vaccines Market 2019-2027 ($ Million)
Figure 21 Italy DNA Vaccines Market 2019-2027 ($ Million)
Figure 22 Russia DNA Vaccines Market 2019-2027 ($ Million)
Figure 23 Rest of Europe DNA Vaccines Market 2019-2027 ($ Million)
Figure 24 India DNA Vaccines Market 2019-2027 ($ Million)
Figure 25 China DNA Vaccines Market 2019-2027 ($ Million)
Figure 26 Japan DNA Vaccines Market 2019-2027 ($ Million)
Figure 27 Australia & New Zealand DNA Vaccines Market 2019-2027 ($ Million)
Figure 28 South Korea DNA Vaccines Market 2019-2027 ($ Million)
Figure 29 Asean Countries DNA Vaccines Market 2019-2027 ($ Million)
Figure 30 Rest of Asia-Pacific DNA Vaccines Market 2019-2027 ($ Million)
Figure 31 Brazil DNA Vaccines Market 2019-2027 ($ Million)
Figure 32 Mexico DNA Vaccines Market 2019-2027 ($ Million)
Figure 33 Rest of Latin America DNA Vaccines Market 2019-2027 ($ Million)
Figure 34 Saudi Arabia DNA Vaccines Market 2019-2027 ($ Million)
Figure 35 Turkey DNA Vaccines Market 2019-2027 ($ Million)
Figure 36 The United Arab Emirates DNA Vaccines Market 2019-2027 ($ Million)
Figure 37 South Africa DNA Vaccines Market 2019-2027 ($ Million)
Figure 38 Rest of Middle East & Africa DNA Vaccines Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Astellas Pharma, Inc.
  • Dendreon Corporation (Acquired By Sanpower Group)
  • Eli Lilly And Company
  • Eurogentec S.A.
  • Glaxosmithkline, Inc.
  • Inovio Pharmaceuticals, Inc.
  • Madison Vaccines Incorporated (Mvi)
  • Merck & Co.
  • Merial Limited (Acquired By Boehringer Ingelheim)
  • Novartis AG
  • Sanofi
  • Vgxi
  • Vical, Incorporated
  • Xenetic Biosciences, Inc.
  • Zoetis, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll